Gene expression analysis of drug-resistant MCF-7 cells: Implications for relation to extracellular matrix proteins

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 3, 2010, Pages 447-455

  Işeri, Özlem Darcansoy ^a   Kars, Meltem Demirel ^a   Arpaci, Fikret ^b   Gündüz, Ufuk ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

ADAM; CDNA microarray; ECM; Integrin; MMP; Multidrug resistance

Indexed keywords

ADAM PROTEIN; COLLAGEN; DOCETAXEL; DOXORUBICIN; FIBRONECTIN; GELATINASE B; INTEGRIN RECEPTOR; INTERSTITIAL COLLAGENASE; PACLITAXEL; PROTEIN ADAM 9; SCLEROPROTEIN; SYNDECAN; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG; VINCRISTINE; ANTINEOPLASTIC AGENT; TAXOID;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UPREGULATION; BREAST TUMOR; CLUSTER ANALYSIS; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METHODOLOGY; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; TAXOIDS; VINCRISTINE;

EID: 75549086984     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1048-z     Document Type: Article

References (46)

1. KL Deuchars V Ling 1989 P-glycoprotein and multidrug resistance in cancer chemotherapy Semin Oncol 16 156 165 1:CAS:528:DyaL1MXktFOjsrg%3D 2565605
2. AM Young CE Allen KL Audus 2003 Efflux transporters of the human placenta Adv Drug Deliver Rev 55 125 132 10.1016/S0169-409X(02)00174-6 1:CAS:528:DC%2BD3sXivVWnug%3D%3D (Pubitemid 36078454)
3. DG Hoyt JM Rusnak RJ Mannix RA Modzelewski CS Johnson JS Lazo 1996 Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells Cancer Res 56 4146 4149 1:CAS:528:DyaK28XlslGgtr8%3D 8797583
4. AC Kraus I Ferber SO Bachmann H Specht A Wimmel, et al. 2002 In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways Oncogene 21 8683 8695 10.1038/sj.onc.1205939 1:CAS:528:DC%2BD38XpsFShtb0%3D 12483521 (Pubitemid 36132389)
5. M Mitsumoto T Kamura H Kobayashi T Sonoda T Kaku H Nakano 1998 Emergence of higher levels of invasive and metastatic properties in the drug-resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice J Cancer Res Clin Oncol 124 607 614 10.1007/s004320050222 1:CAS:528:DyaK1cXnslWlsLg%3D 9860289 (Pubitemid 28552996)
6. PJ Morin 2003 Drug resistance and the microenvironment: nature and nurture Drug Resist Updat 4 169 172 10.1016/S1368-7646(03)00059-1 (Pubitemid 37129916)
7. MD Kars OD Işeri U Gündüz AU Ural F Arpaci J Molnar 2006 Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds Anticancer Res 26 4559 4568 1:CAS:528:DC%2BD2sXpslGhtg%3D%3D 17201178
8. ÖD Iseri MD Kars S Eroglu U Gündüz 2009 Cross-resistance development and combined applications of anticancer agents in drug resistant MCF-7 cell lines Int J Hem Oncol 1 19 1 8
9. R Yilmaz M Yücel HA Öktem 2008 Quality assessment of gene expression data for an affymetrix platform with the two sample t-tests statistical analysis Int J Biotechnol Biochem 4 101 108 10.3844/ajbbsp.2008.101. 104
10. QQ Li WJ Wang JD Xu XX Cao Q Chen JM Yang ZD Xu 2007 Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells Cancer Sci 98 11 1767 1774 10.1111/j.1349-7006.2007.00593.x 1:CAS:528:DC%2BD2sXht1eis7nI 17725804 (Pubitemid 47487914)
11. RS Weinstein SM Jakate JM Dominguez MD Lebovitz GK Koukoulis JR Kuszak, et al. 1991 Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis Cancer Res 51 10 2720 2726 1:CAS:528: DyaK3MXktVKju7Y%3D 1673639
12. N Ahmed C Riley G Rice M Quinn 2005 Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment Clin Exp Metastasis 22 5 391 402 10.1007/s10585-005-1262-y 1:CAS:528:DC%2BD28Xit1KltQ%3D%3D 16283482 (Pubitemid 41609298)
13. T Sethi RC Rintoul SM Moore AC MacKinnon D Salter C Choo, et al. 1999 Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo Nat Med 6 662 668 10.1038/9511 (Pubitemid 29289430)
14. A Nista C Leonetti G Bernardini M Mattioni A Santoni 1997 Functional role of alpha4beta1 and alpha5beta1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells Int J Cancer 72 1 133 141 10.1002/(SICI)1097-0215(19970703)72:1<133::AID-IJC19>3.0.CO;2-K 1:CAS:528:DyaK2sXkslahtrk%3D 9212234 (Pubitemid 27314650)
15. T Narita N Kimura M Sato N Matsuura R Kannagi 1998 Altered expression of integrins in adriamycin-resistant human breast cancer cells Anticancer Res 18 1A 257 262 1:CAS:528:DyaK1cXivVajurY%3D 9568087
16. Y Liang P Meleady I Cleary S McDonnell L Connolly M Clynes 2001 Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness Eur J Cancer 37 8 1041 1052 10.1016/S0959-8049(01)00086-7 1:CAS:528: DC%2BD3MXjtFCnsL0%3D 11334731 (Pubitemid 32397691)
17. F Aoudjit K Vuori 2001 Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells Oncogene 20 36 4995 5004 10.1038/sj.onc.1204554 1:CAS:528:DC%2BD3MXmtlCks74%3D 11526484 (Pubitemid 32769789)
18. K Shibata F Kikkawa A Nawa N Suganuma M Hamaguchi 1997 Fibronectin secretion from human peritoneal tissue induces Mr 92,000 type IV collagenase expression and invasion in ovarian cancer cell lines Cancer Res 57 23 5416 5420 1:CAS:528:DyaK2sXnslGqs70%3D 9393769
19. J Esparza C Vilardell J Calvo M Juan J Vives A Urbano-Márquez, et al. 1999 Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines A process repressed through RAS/MAP kinase signaling pathways Blood 94 8 2754 2766 1:CAS:528:DyaK1MXmslansbc%3D 10515879
20. PD Leotlela MS Wade PH Duray MJ Rhode HF Brown DT Rosenthal, et al. 2007 Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility Oncogene 26 26 3846 3856 10.1038/sj.onc.1210155 1:CAS:528:DC%2BD2sXlvFaksro%3D 17160014 (Pubitemid 46880988)
21. D Modrowski A Orosco J Thévenard O Fromigué PJ Marie 2005 Syndecan-2 overexpression induces osteosarcoma cell apoptosis: implication of syndecan-2 cytoplasmic domain and JNK signaling Bone 37 2 180 189 10.1016/j.bone.2005.04.010 1:CAS:528:DC%2BD2MXmtFSnsbg%3D 15936998 (Pubitemid 40962425)
22. A Orosco O Fromigué C Bazille N Entz-Werle P Levillain PJ Marie D Modrowski 2007 Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma Cancer Res 67 8 3708 3715 10.1158/0008-5472.CAN-06-4164 1:CAS:528:DC%2BD2sXkt1Kisb0%3D 17440083 (Pubitemid 46762156)
23. CY Fears CL Gladson A Woods 2006 Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells J Biol Chem 281 21 14533 14536 10.1074/jbc.C600075200 1:CAS:528:DC%2BD28XkslGqsr0%3D 16574663 (Pubitemid 43855155)
24. L Chen C Klass A Woods 2004 Syndecan-2 regulates transforming growth factor-beta signaling J Biol Chem 279 16 15715 15718 10.1074/jbc.C300430200 1:CAS:528:DC%2BD2cXivF2rtbw%3D 14976204 (Pubitemid 38509254)
25. SS Chaudhry SA Cain A Morgan SL Dallas CA Shuttleworth CM Kielty 2007 Fibrillin-1 regulates the bioavailability of TGFbeta1 J Cell Biol 176 3 355 367 10.1083/jcb.200608167 1:CAS:528:DC%2BD2sXhsVWltbg%3D 17242066 (Pubitemid 46184886)
26. SM Pupa S Giuffré F Castiglioni L Bertola M Cantú I Bongarzone, et al. 2007 Regulation of breast cancer response to chemotherapy by fibulin-1 Cancer Res 67 9 4271 4277 10.1158/0008-5472.CAN-06-4162 1:CAS:528:DC%2BD2sXltVyrsL4%3D 17483339 (Pubitemid 46815074)
27. YH Lee AR Albig R Maryann BJ Schiemann WP Schiemann 2008 Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-β in mammary epithelial cells via a MMP-dependent mechanism Carcinogenesis 29 12 2243 2251 10.1093/carcin/bgn199 1:CAS:528: DC%2BD1cXhsVOgsLfO 18713838
28. Z Han J Ni P Smits CB Underhill B Xie Y Chen, et al. 2001 Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells FASEB J 15 6 988 994 10.1096/fj.99-0934com 1:CAS:528: DC%2BD3MXivFOrtLo%3D 11292659 (Pubitemid 32290786)
29. DF Seals SA Courtneidge 2003 The ADAMs family of metalloproteases: multidomain proteins with multiple functions Genes Dev 17 7 30 10.1101/gad.1039703 1:CAS:528:DC%2BD3sXktlKrtg%3D%3D 12514095 (Pubitemid 36062504)
30. B Lovejoy AR Welch S Carr C Luong C Broka RT Hendricks, et al. 1999 Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors Nat Struct Biol 6 217 221 10.1038/6657 1:CAS:528:DyaK1MXhs12rtL8%3D 10074939 (Pubitemid 29107223)
31. NJ Turton DJ Judah J Riley R Davies D Lipson JA Styles, et al. 2001 Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance Oncogene 20 11 1300 1306 10.1038/sj.onc.1204235 1:CAS:528:DC%2BD3MXisFWhu7Y%3D 11313874 (Pubitemid 32269935)
32. RPT Somerville SA Oblander SS Apte 2003 Matrix metalloproteinases: old dogs with new tricks Genome Biol 4 6 216 10.1186/gb-2003-4-6-216 12801404 (Pubitemid 36758193)
33. M Stefanidakis E Koivunen 2006 Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression Blood 108 5 1441 1450 10.1182/blood-2006-02-005363 1:CAS:528:DC%2BD28Xpt1SltrY%3D 16609063 (Pubitemid 44316107)
34. G Bergers R Brekken G McMahon TH Vu T Itoh K Tamaki, et al. 2000 Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat Cell Biol 2 10 737 744 10.1038/35036374 1:CAS:528:DC%2BD3cXnsVyntLk%3D 11025665 (Pubitemid 30768157)
35. LM Coussens CL Tinkle D Hanahan Z Werb 2000 MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 103 3 481 490 10.1016/S0092-8674(00)00139-2 1:CAS:528:DC%2BD3cXnvF2ksLg%3D 11081634
36. OM Fischer S Hart A Gschwind N Prenzel A Ullrich 2004 Oxidative and osmotic stress signaling in tumor cells is mediated by ADAM proteases and heparin-binding epidermal growth factor Mol Cell Biol 24 12 5172 5183 10.1128/MCB.24.12.5172-5183.2004 1:CAS:528:DC%2BD2cXkvFOqtrs%3D 15169883 (Pubitemid 38738154)
37. J Krätzschmar L Lum CP Blobel 1996 Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence J Biol Chem 271 9 4593 4596 10.1074/jbc.271.9.4593 8617717
38. V Trochon-Joseph D Martel-Renoir LM Mir A Thomaïdis P Opolon E Connault, et al. 2004 Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin Cancer Res 64 6 2062 2069 10.1158/0008-5472.CAN-03-3272 1:CAS:528:DC%2BD2cXitFCgtbg%3D 15026344 (Pubitemid 38339454)
39. V Beck H Herold A Benge B Luber P Hutzler H Tschesche, et al. 2005 ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion Int J Biochem Cell Biol 37 3 590 603 10.1016/j.biocel.2004.08.005 1:CAS:528:DC%2BD2cXhtFGiu7rF 15618016 (Pubitemid 40022936)
40. S Mochizuki Y Okada 2007 ADAMs in cancer cell proliferation and progression Cancer Sci 98 5 621 628 10.1111/j.1349-7006.2007.00434.x 1:CAS:528:DC%2BD2sXkvFSktb0%3D 17355265 (Pubitemid 46563436)
41. YJ Liu Y Xu Q Yu 2006 Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively Oncogene 25 17 2452 2467 10.1038/sj.onc.1209287 1:CAS:528:DC%2BD28Xjs1ansr8%3D 16314835
42. S Porter SD Scott EM Sassoon MR Williams JL Jones AC Girling RY Ball DR Edwards 2004 Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma Clin Cancer Res 10 7 2429 2440 10.1158/1078-0432.CCR-0398-3 1:CAS:528:DC%2BD2cXivFSqsL0%3D 15073121 (Pubitemid 38445703)
43. M Ahonen AH Baker VM Kähäri 1998 Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells Cancer Res 58 11 2310 2315 1:CAS:528:DyaK1cXjs12ru78%3D 9622064
44. MR Smith H Kung SK Durum NH Colburn Y Sun 1997 TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells Cytokine 9 10 770 780 10.1006/cyto.1997.0233 1:CAS:528:DyaK2sXnsVGmtrw%3D 9344510 (Pubitemid 27477722)
45. A Amour PM Slocombe A Webster M Butler CG Knight BJ Smith, et al. 1998 TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3 FEBS Lett 435 1 39 44 10.1016/S0014-5793(98)01031-X 1:CAS:528:DyaK1cXmtlSitb4%3D 9755855 (Pubitemid 28432011)
46. Y Jiang M Wang MY Celiker YE Liu QX Sang ID Goldberg YE Shi 2001 Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery Cancer Res 61 6 2365 2370 1:CAS:528: DC%2BD3MXisVSltbg%3D 11289097